Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ConmedMEX:CNMD 80 Market Cap is MXN26,094 Mil as of Aug. 21, 2026. GuruFocus rates MEX:CNMD with a GF Score™ of 80/100 and a GF Value™ of MXN945.33. The stock has 5 warning signs investors should review. Among 859 Medical Devices & Instruments companies, Conmed ranks better than 83.7% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Conmed's share price for the quarter that ended in Jun. 2026 was MXN720. Conmed's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 30 Mil. Therefore, Conmed's market cap for the quarter that ended in Jun. 2026 was MXN21,591 Mil.
Conmed's quarterly market cap
declined
from Dec. 2025 (MXN25,378 Mil) to Mar. 2026 (MXN21,704 Mil) and
declined
from Mar. 2026 (MXN21,704 Mil) to Jun. 2026 (MXN21,591 Mil).
Conmed's annual market cap
declined
from Dec. 2023 (MXN57,958 Mil) to Dec. 2024 (MXN44,930 Mil) and
declined
from Dec. 2024 (MXN44,930 Mil) to Dec. 2025 (MXN25,378 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Conmed's Enterprise Value for Today is MXN39,608 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Conmed Market Cap Related Terms
Conmed Market Cap Historical Data
* Premium members only.
The historical data trend for Conmed's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CNMD vs ATEC, AORT, IRMD: Market Cap Comparison
For the Medical Devices subindustry, Conmed's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conmed Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Market Cap distribution charts can be found below:
* The bar in red indicates where Conmed's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Conmed's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conmed (MEX:CNMD) has a Market Cap of MXN26,094 Mil as of Aug. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Conmed and its competitors. According to the industry distribution chart, Conmed ranks #140 out of 859 companies in the Medical Devices & Instruments industry, placing it in the top 16.3%.
Is Conmed's Market Cap too high?
Conmed's current Market Cap is MXN26,094 Mil. Based on the distribution chart, Conmed ranks #140 out of 859 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Conmed has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Conmed's Market Cap compare to ATEC and AORT?
According to the Medical Devices & Instruments industry distribution chart, Conmed ranks #140 out of 859 companies for Market Cap. This places Conmed in the top 16% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.46, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Conmed and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conmed's current Market Cap is MXN26,094 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Conmed (MEX:CNMD) has a current Market Cap of MXN26,094 Mil. The stock's GF Value™ is MXN945.33, compared to a current price of MXN720.00 — trading 23.8% below its estimated fair value. The current Market Cap is MXN26,094 Mil. Conmed's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Conmed (MEX:CNMD), the current Market Cap is MXN26,094 Mil as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Conmed (MEX:CNMD) Overvalued in 2026?
Based on GuruFocus' analysis, Conmed stock appears to be undervalued.
The current stock price of MXN720.00 is trading 23.8% below its estimated GF Value™ of MXN945.33.
Key valuation signals for MEX:CNMD:
Market Cap: MXN26,094 Mil
GF Value™: MXN945.33 vs. price of MXN720.00 (23.8% below fair value)
No single metric tells the full story. See the MEX:CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score
Get the complete analysis for MEX:CNMD
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CNMD has been successfully added to your 
